共 12 条
[1]
PET/CT for atherosclerotic plaque imaging. Ben-Haim S,Israel O. Q J Nucl Med Mol Imaging . 2006
[2]
Functionally defective high-den- sity lipoprotein:a new therapeutic target at the crossroads of dyslipidemia,inflammation,and atherosclerosis. Kontush A,Chapman MJ. Pharmacology Reviews . 2006
[3]
Atheroselerosis:immunopa- thogenesis and immunotherapy. Ohashi R,Mu H,Yao Q,et al. Medical Science Monitor . 2004
[4]
Overview of prevention and treatment of atheroselerosis with ipid-altering therapy for pharmacy di- rectors. Davidson MH. American Journal of Managed Care . 2007
[5]
Diagnostic criteria for dyslipidemia-exeeutive summary of japan atheroselero- sis society (JAS) guideline for diagnosis and prevention of atherosclerotic cardiovascular diseases for japanese. Teramoto T,Sasaki J,Ueshima H,et al. J A therosclerosis and Thrombosis . 2007
[6]
Endothelial dysfunction: cardiovascular risk factors,therapy,and outcome. Hadi HA,Cart CS,A1 Suwaidi J. Vasc Health Risk Manag . 2005
[7]
Thrombus formation on atheroselerotic plaques:pathogenesis and clinical con- sequences. Ranch U,Osende JI,Fuster V,et al. Annals of Internal Medicine . 2001
[8]
Lipid Changes and Statins in Chronic re- nal insufficiency. Ritz E,Wanne C. Journal of the American Society of Nephrology . 2006
[9]
Implications of Early Structural-Functional Changes in the Endothelium for Vascular Disease. Simionescu,Maya. Arteriosclerosis . 2007
[10]
Atherogenesis: Current understanding of the causes of atheroma. Weissberg PL. Heart . 2000